Citius Oncology (CTOR) Research & Development (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Research & Development of $1.1 million for Q1 2026, down 65.62% year-over-year from $3.1 million in Q1 2025, and up 5.99% quarter-over-quarter from $1.0 million in Q4 2025.
Citius Oncology (CTOR) Research & Development (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Research & Development for 4 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 65.62% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $8.0 million (down 4.4% YoY), while the FY2025 annual figure was $6.4 million, up 226.86% from the prior year.
- Research & Development climbed to $1.1 million in Q1 2026 per CTOR's latest filing, from $1.0 million in the prior quarter.
- Across five years, Research & Development topped out at $5.0 million in Q3 2025 and bottomed at $483063.0 in Q4 2023.
- Historically, Research & Development has averaged $1.9 million across 4 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2024 — Research & Development soared 161.77% — and 2026, when it tumbled 65.62%.
- Citius Oncology's Research & Development stood at $483063.0 in 2023, then jumped by 161.77% to $1.3 million in 2024, then declined by 19.47% to $1.0 million in 2025, then climbed by 5.99% to $1.1 million in 2026.
- Business Quant data shows CTOR's Research & Development at $1.1 million in Q1 2026, $1.0 million in Q4 2025, and $5.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Citius Oncology | 79.62 Mn | 79.62 Mn | 1.00 Mn | 256,231.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 4.98 Mn |
| Jun 30, 2025 | 938,277.00 |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 483,063.00 |